Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Biophytis SA Sponsored ADR (BPTS : NSDQ)
 
 • Company Description   
Biophytis SA is a clinical-stage biotechnology company. It specialized in the development of therapeutics which slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19. Biophytis SA is based in CAMBRIDGE, Mass.

Number of Employees: 25

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.16 Daily Weekly Monthly
20 Day Moving Average: 6,411 shares
Shares Outstanding: 13.65 (millions)
Market Capitalization: $15.84 (millions)
Beta: 0.74
52 Week High: $13.17
52 Week Low: $1.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -43.41% -36.27%
12 Week -65.17% -61.71%
Year To Date -78.28% -67.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SORBONNE UNIVERSITY BC 9 BATIMENT A 4EME ETAGE 4 PLACE JUSSIEU
-
PARIS,I0 75005
FRA
ph: 33-1-44-37-23-00
fax: -
None http://www.biophytis.com
 
 • General Corporate Information   
Officers
Stanislas Veillet - Chief Executive Officer and Chairman
Philippe Rousseau - Chief Financial Officer
Claude Allary - Director
Dimitri Batsis - Director
Nadine Coulm - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09076G104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 13.65
Most Recent Split Date: (:1)
Beta: 0.74
Market Capitalization: $15.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.50 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.08
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 1.37
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 1.37
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 0.56
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 1.10
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 52.45
09/30/21 - -
 

Powered by Zacks Investment Research ©